Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-26-043518
Filing Date
2026-04-14
Accepted
2026-04-14 16:01:01
Documents
1
Period of Report
2026-04-14

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0286336-6k_clearmind.htm 6-K 9862
  Complete submission text file 0001213900-26-043518.txt   10926
Mailing Address 101-1220 WEST 6TH AVENUE VANCOUVER, BRITISH COLUMBIA Z4 V6H1A5
Business Address 101-1220 WEST 6TH AVENUE VANCOUVER, BRITISH COLUMBIA Z4 V6H1A5 972-54-5704749
Clearmind Medicine Inc. (Filer) CIK: 0001892500 (see all company filings)

EIN.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1031
Type: 6-K | Act: 34 | File No.: 001-41557 | Film No.: 26860812
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)